Sigma-Aldrich Corp. (SIAL) Releases FY13 Earnings Guidance
Sigma-Aldrich Corp. (NASDAQ:SIAL) updated its FY13 earnings guidance on Tuesday. The company provided EPS guidance of $4.05-4.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.08, AR Network reports.
Shares of Sigma-Aldrich Corp. (NASDAQ:SIAL) opened at 83.32 on Tuesday. Sigma-Aldrich Corp. has a one year low of $68.22 and a one year high of $88.55. The stock’s 50-day moving average is $84.67 and its 200-day moving average is $82.45. The company has a market cap of $10.018 billion and a price-to-earnings ratio of 21.59.
Sigma-Aldrich Corp. (NASDAQ:SIAL) last issued its quarterly earnings data on Tuesday, October 22nd. The company reported $1.05 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.99 by $0.06. The company had revenue of $664.00 million for the quarter, compared to the consensus estimate of $661.29 million. During the same quarter in the prior year, the company posted $0.94 earnings per share. The company’s quarterly revenue was up 3.9% on a year-over-year basis.
The company also recently announced a quarterly dividend, which is scheduled for Friday, December 13th. Shareholders of record on Friday, November 29th will be paid a dividend of $0.22 per share. This represents a $0.86 annualized dividend and a dividend yield of 1.03%. The ex-dividend date is Tuesday, November 26th.
SIAL has been the subject of a number of recent research reports. Analysts at Morgan Stanley initiated coverage on shares of Sigma-Aldrich Corp. in a research note to investors on Thursday, October 17th. They set an underweight rating and a $82.00 price target on the stock. On a related note, analysts at Goldman Sachs Group Inc. raised their price target on shares of Sigma-Aldrich Corp. from $69.00 to $73.00 in a research note to investors on Friday, September 27th. They now have a sell rating on the stock. Finally, analysts at Robert W. Baird downgraded shares of Sigma-Aldrich Corp. from an outperform rating to a neutral rating in a research note to investors on Friday, September 20th. They now have a $80.00 price target on the stock. Five equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $78.55.
Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes the range of chemicals, biochemicals and equipment available globally and also provides global biopharmaceutical testing services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.